Honduras' Fiscal Outlook Improves as External Debt Shows Slight Decline
Ana Fernanda Reporter
| 2025-03-09 05:10:18
Tegucigalpa, Honduras – The Central Bank of Honduras (BCH) has released data indicating a slight improvement in the nation's external debt situation. As of January 2025, Honduras' external debt was recorded at $10.219 billion, reflecting a decrease of $22.8 million from the previous month.
The BCH's report attributes this minor reduction to a combination of factors. Primarily, the nation experienced a net amortization of $17.5 million, meaning that capital payments of $21 million surpassed the $3.5 million in disbursements received. Additionally, a favorable shift in exchange rates contributed to a $5.3 million decrease in the overall debt balance.
This positive trend is further highlighted by the nation's debt-to-GDP ratio, which now stands at 25.3%. This marks a 2.2 percentage point improvement compared to the end of the previous fiscal year, indicating a strengthening of Honduras' economic position.
Furthermore, the Honduran government has demonstrated its commitment to meeting its financial obligations. In January, the nation successfully made $50.5 million in debt service payments to its various creditors, including multilateral, bilateral, and commercial entities.
This data suggests that Honduras is making strides in managing its external debt, which could have positive implications for the nation's economic stability and future growth. Continued responsible fiscal management will be crucial for maintaining this positive trajectory.
WEEKLY HOT
- 1"Steak Without Meat?" EU Bans Meat Terminology for Plant-Based Foods
- 2Historian Warns of 'Dictatorial Shift': Trump May Use Emergency Powers to Postpone November Elections
- 3Danawa Hosts 1,000 KRW Raffle for 1TB SSD Worth Over 300,000 KRW
- 4Apple's Next Leap: Will the 'MacBook Ultra' with OLED and Touch Support Redefine the Premium Laptop Market?
- 5KEXIM Ignites 'K-Finance' with 450 Billion Won Support for Taihan Cable’s Submarine Plant
- 6Japan Approves World's First iPSC-Derived Therapies: A New Era for Regenerative Medicine